EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Endogenous Ribonucleases: Therapeutic Targeting of the Transcriptome Through Oligonucleotide-Triggered RNA Inactivation

Daria A Chiglintseva iD, Olga A Patutina iD, Marina A Zenkova iD

Biomolecules · 04.07.2025 · 15 (7) · 965

DOI: 10.3390/biom15070965 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 04.07.2025. Verfasst von Daria A Chiglintseva und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Nucleic Acids Biochemistry, Institute of Chemical Biology and Fundamental Medicine SB RAS, 630090 Novosibirsk, Russia. Hauptthemen laut MEDLINE: Transcriptome, Ribonucleases, Oligonucleotides, Antisense, Oligonucleotides. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 216 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The selective regulation of gene expression at the RNA level represents a rapidly evolving field offering substantial clinical potential. This review examines the molecular mechanisms of intracellular enzymatic systems that utilize single-stranded nucleic acids to downregulate specific RNA targets. The analysis encompasses antisense oligonucleotides and synthetic mimics of small interfering RNA (siRNA), microRNA (miRNA), transfer RNA-derived small RNA (tsRNA), and PIWI-interacting RNA (piRNA), elucidating their intricate interactions with crucial cellular machinery, specifically RNase H1, RNase P, AGO, and PIWI proteins, mediating their biological effects. The functional and structural characteristics of these endonucleases are examined in relation to their mechanisms of action and resultant therapeutic outcomes. This comprehensive analysis illuminates the interactions between single-stranded nucleic acids and their endonuclease partners, covering antisense inhibition pathways as well as RNA interference processes. This field of research has important implications for advancing targeted RNA modulation strategies across various disease contexts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TranscriptomeRibonucleasesOligonucleotides, AntisenseOligonucleotidesHumansAnimalsRNA, Small InterferingMicroRNAsRNA Interference

Stichwörter der Autor:innen

AGO2EGSRNA-targeted therapyRNase H1RNase Pantisense oligonucleotidemiRNApiRNAsiRNAtsRNA

Substanzen

RibonucleasesOligonucleotides, AntisenseRNA, Small InterferingMicroRNAsOligonucleotides

Autor:innen und Institutionen

  • Laboratory of Nucleic Acids Biochemistry, Institute of Chemical Biology and Fundamental Medicine SB RAS, 630090 Novosibirsk, Russia.

ORCID-Profile: Daria A Chiglintseva, Olga A Patutina, Marina A Zenkova

Förderung

  • Russian Science Foundation

Zitieren

APA

Chiglintseva, D. A., Patutina, O. A., & Zenkova, M. A. (2025). Endogenous Ribonucleases: Therapeutic Targeting of the Transcriptome Through Oligonucleotide-Triggered RNA Inactivation. Biomolecules, 15(7), 965. https://doi.org/10.3390/biom15070965

Vancouver

Chiglintseva DA, Patutina OA, Zenkova MA. Endogenous Ribonucleases: Therapeutic Targeting of the Transcriptome Through Oligonucleotide-Triggered RNA Inactivation. Biomolecules. 2025;15(7):965. doi:10.3390/biom15070965

BibTeX
@article{Chiglintseva2025,
  author = {Chiglintseva, Daria A and Patutina, Olga A and Zenkova, Marina A},
  title = {Endogenous Ribonucleases: Therapeutic Targeting of the Transcriptome Through Oligonucleotide-Triggered RNA Inactivation},
  journal = {Biomolecules},
  year = {2025},
  volume = {15},
  number = {7},
  pages = {965},
  doi = {10.3390/biom15070965}
}
Kostenlos starten →